ACAN.US Americann Inc
- Market cap
- USD 2.44K
- P/E
- -
- P/B
- 0.00x
- ROE
- -164.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Dec 2024.
Is ACAN.US undervalued?
Graham numberThe Graham number of Americann Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Americann Inc fundamental analysis
No fundamental analysis for Americann Inc yet.
Americann Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Americann Inc
AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States. The company's flagship project is the Massachusetts Cannabis Center that is developed on a 52.6 -acre parcel of undeveloped land located in Freetown, Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The com…
Full company profileAmericann Inc financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 1 quarter up to Dec 31, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
Americann Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 140K | 60.0K | 40.0K | 0.00 | 11.6K | 504K | 2.03M | 2.93M | 2.55M | 1.28M | 1.90M |
| Gross Profit | 140K | 60.0K | 40.0K | -13.8K | 11.6K | 481K | 1.99M | 2.88M | 2.54M | 1.27M | 1.90M |
| Operating Income | -1.81M | -1.13M | -2.44M | -2.03M | -3.39M | -187K | 44.3K | 483K | 612K | -746K | -1.79M |
| EBITDA | -1.59M | -1.92M | -2.41M | -1.97M | -4.34M | 661K | 581K | 1.01M | 1.14M | -172K | -4.25M |
| Net Income | -1.73M | -2.21M | -2.77M | -4.43M | -4.90M | -709K | -863K | -173K | -94.8K | -1.25M | -5.20M |
| EPS | -0.10 | -0.13 | -0.15 | -0.22 | -0.21 | -0.03 | -0.04 | -0.01 | 0.00 | -0.05 | -0.21 |
| Balance Sheet | |||||||||||
| Total Assets | 3.99M | 4.37M | 6.06M | 9.46M | 11.8M | 14.9M | 15.1M | 15.4M | 15.2M | 14.1M | 10.1M |
| Total Liabilities | 2.68M | 3.76M | 3.78M | 2.63M | 5.66M | 8.99M | 9.55M | 9.64M | 9.45M | 9.61M | 6.99M |
| Shareholders' Equity | 1.31M | 609K | 2.28M | 6.83M | 6.11M | 5.87M | 5.51M | 5.80M | 5.71M | 4.45M | 3.15M |
| Cash & Short-term Investments | 201K | 24.00 | 1.63K | 198K | 466K | 183K | 696K | 1.34M | 1.14M | 48.8K | 131K |
| Total Debt | 2.58M | 3.18M | 3.05M | 2.30M | 5.26M | 8.56M | 9.20M | 9.30M | 9.30M | 9.29M | 6.79M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -793K | -541K | -1.75M | -2.40M | -2.19M | 518K | -275K | 849K | 580K | -1.17M | -2.37M |
| Capital Expenditure | 41.5K | 501K | 501K | 703K | 5.89M | 386K | 93.4K | 246K | 279K | 956.00 | 11.5K |
| Free Cash Flow | -834K | -541K | -2.25M | -3.11M | -8.08M | 132K | -369K | 603K | 301K | -1.17M | -2.39M |
| Ratios | |||||||||||
| ROE | -131.5% | -363.0% | -121.4% | -64.9% | -80.3% | -12.1% | -15.7% | -3.0% | -1.7% | -28.2% | -164.7% |
| ROA | -43.3% | -50.6% | -45.7% | -46.9% | -41.7% | -4.8% | -5.7% | -1.1% | -0.6% | -8.9% | -51.2% |
| Net Profit Margin | -1,235.0% | -3,685.0% | -6,930.0% | - | -42,407.5% | -140.8% | -42.5% | -5.9% | -3.7% | -98.4% | -273.1% |
| Debt to Equity | 1.96x | 5.23x | 1.33x | 0.34x | 0.86x | 1.46x | 1.67x | 1.60x | 1.63x | 2.09x | 2.15x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Americann Inc dividends
Americann Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 5:1 on Apr 10, 2014.
Who owns Americann Inc
- Insiders 37.42%
- Institutions 0.00%
- Public & others 62.58%
- Shares outstanding 24.4M
- Free float 15.3M
Americann Inc company profile
- Company name
- Americann Inc
- Ticker
- ACAN.US
- Exchange
- USA Stocks
- Sector
- Real Estate
- Industry
- Professional Services
- Employees
- 3
- Fiscal year end
- September
- Address
- 1555 Blake Street, Denver, CO, United States, 80202
- Phone
- 303 862 9000
- Website
- americann.co
About Americann Inc
AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States. The company's flagship project is the Massachusetts Cannabis Center that is developed on a 52.6 -acre parcel of undeveloped land located in Freetown, Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The company was incorporated in 2010 and is headquartered in Denver, Colorado.
Americann Inc management
2- Mr. Timothy Ryan KeoghCEO, President & Director · born 1980
- Mr. Benjamin J. BartonFounder, Chief Financial & Accounting Officer and Director · born 1965